Description

Neuromidin (ipidacrine hydrochloride) tablets 20 mg. №50

Ingredients:

Each tablet contains 20 mg of ipidacrine hydrochloride.

Dosage:

The recommended dosage is one 20 mg tablet taken orally three times a day.

Indications:

Neuromidin tablets are indicated for the treatment of myasthenia gravis and other neuromuscular disorders.

Contraindications:

Do not use Neuromidin tablets if you are allergic to ipidacrine hydrochloride or any other ingredients in the formulation.

Directions:

Take Neuromidin tablets exactly as prescribed by your healthcare provider. Do not exceed the recommended dosage.

Scientific Evidence:

Studies have shown that ipidacrine hydrochloride, the active ingredient in Neuromidin tablets, acts as a reversible cholinesterase inhibitor, leading to increased acetylcholine levels at the neuromuscular junction. This mechanism of action helps improve muscle strength and function in patients with myasthenia gravis.

Furthermore, clinical trials have demonstrated the efficacy of ipidacrine hydrochloride in improving neuromuscular transmission and reducing symptoms of fatigue and weakness associated with myasthenia gravis.

Additional Information:

It is important to follow the prescribed dosage and frequency of Neuromidin tablets to achieve optimal therapeutic effects. Consult your healthcare provider for any questions or concerns regarding the use of this medication.

Neuromidin tablets have been well-tolerated in clinical studies, with common side effects including gastrointestinal disturbances and cholinergic symptoms. If you experience any severe or persistent side effects, seek medical attention promptly.